APA (7th ed.) Citation

D, P., C, J., K, H., R, V., F, H., P, L. C., . . . E, B. (2024). The Association Between Short-Acting β2-Agonist Over-Prescription, and Patient-Reported Acquisition and Use on Asthma Control and Exacerbations: Data from Australia. Advances in therapy, 41(3), 1262. https://doi.org/10.1007/s12325-023-02746-0

Chicago Style (17th ed.) Citation

D, Price, et al. "The Association Between Short-Acting β2-Agonist Over-Prescription, and Patient-Reported Acquisition and Use on Asthma Control and Exacerbations: Data from Australia." Advances in Therapy 41, no. 3 (2024): 1262. https://doi.org/10.1007/s12325-023-02746-0.

MLA (9th ed.) Citation

D, Price, et al. "The Association Between Short-Acting β2-Agonist Over-Prescription, and Patient-Reported Acquisition and Use on Asthma Control and Exacerbations: Data from Australia." Advances in Therapy, vol. 41, no. 3, 2024, p. 1262, https://doi.org/10.1007/s12325-023-02746-0.